The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,150.00
Bid: 1,146.00
Ask: 1,149.00
Change: 36.00 (3.23%)
Spread: 3.00 (0.262%)
Open: 1,125.00
High: 1,150.00
Low: 1,124.00
Prev. Close: 1,114.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 May 2023 16:05

RNS Number : 0653B
Hiscox Ltd
30 May 2023
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

 

 

Hamilton, Bermuda (30 May 2023) - On 23 May 2023 awards ("Awards") were made to Executive Directors pursuant to the Company's Performance Share Plan ("Performance Share Plan"), to acquire ordinary 6.5p shares ("Shares") in the Company.

 

The Awards granted to the Executive Directors are subject to performance conditions measured over the three financial years from 1 January 2023 to 31 December 2026.

 

The performance measures for the Executive Directors will be as set out in the annual report on remuneration in the Annual Report, with 50% of the awards based net asset value (NAV) plus dividends targets averaged over the three performance years, and 50% based on relative total shareholder return (TSR) against a group of the Company's closest listed peers.

 

The performance conditions for NAV plus dividends-related element of the Awards are measured against the growth in NAV plus dividends, on a per share basis, and will not vest if the growth in NAV plus dividends per share is less than $0.43 per annum. 20% of the award will vest if the growth in NAV plus dividends per share is equal to $0.43 per annum, rising on a straight-line basis up to a maximum of 100% vesting if the growth in NAV plus dividends per share is equal to or exceeds $1.28 per annum.

 

The performance conditions for the TSR-related element of the Awards are measured against relative TSR. The relative TSR condition assesses the Company's share price and dividend performance relative to that of the comparator group of companies made up of the Company's closest listed peers over the three year performance period.  20% of the award will vest if performance is at the median, rising on a straight-line basis up to a maximum of 100% if the performance is in the upper quartile based on ranking.

 

Subject to the satisfaction of the performance conditions, Awards will vest on 15 May 2026. The Awards granted to the Executive Directors are subject to a further two year holding period.

 

Details of the number of Shares over which Awards were granted are set out in the table below.

 

 

HA Hussain

168,269

 

J Musselle

106,009

P Cooper

106,009

 

 

 

The Awards were granted from Bermuda.

 

The notifications set out below are made in accordance with the UK version of the EU Market Abuse Regulation (2014/596/EU) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

Marc Wetherhill

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Hamayou Akbar (Aki) Hussein 

2

 

Reason for the notification

 

a)

 

Position/status

PDMR - Group Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Hiscox Ltd

b)

 

LEI

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

b)

 

Nature of the transaction

Grant of performance-based award over shares under the Company's Performance Share Plan

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

nil

168,269

 

d)

 

Aggregated information

 

 - Aggregated volume

 

 - Price

 

Aggregated Volume

 

Aggregated Price

Total Price

168,269

nil

nil

e)

 

Date of the transaction

2023-05-23

f)

 

Place of the transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Joanne Musselle

2

 

Reason for the notification

 

a)

 

Position/status

PDMR - Group Chief Underwriting Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Hiscox Ltd

b)

 

LEI

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

b)

 

Nature of the transaction

Grant of performance-based award over shares under the Company's Performance Share Plan

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

nil

106,009

d)

 

Aggregated information

 

 - Aggregated volume

 

 - Price

 

Aggregated Volume

 

Aggregated Price

Total Price

106,009

nil

nil

e)

 

Date of the transaction

2023-05-23

f)

 

Place of the transaction

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Paul Cooper

2

 

Reason for the notification

 

a)

 

Position/status

PDMR - Group Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Hiscox Ltd

b)

 

LEI

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

b)

 

Nature of the transaction

Grant of performance-based award over shares under the Company's Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

nil

106,009

d)

 

Aggregated information

- Aggregated volume

 

 - Price

 

Aggregated Volume

 

Aggregated Price

Total Price

106,009

nil

nil

e)

 

Date of the transaction

2023-05-23

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDUBGXDGXG
Date   Source Headline
16th Jan 20233:13 pmRNSDirector/PDMR Shareholding
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer
13th Dec 20215:54 pmRNSDirector/PDMR Shareholding
6th Dec 20214:20 pmRNSTR-1:Standard form-notification major shareholding
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.